🚀 Early Adopter Price: $39/mo for life --d --h --m --s Claim Your Price →
Coming Soon
Expected availability announced soon

This course is in active development. Preview the scope below and create a free account to be notified the moment it goes live.

Notify me
Continuing Education Coming Soon

CE Medication Safety

The course teaches medication safety fundamentals, covering rights of administration, high-alert drugs, look‑alike/sound‑alike risks, reconciliation, and interaction management, enabling clinicians to prevent errors and protect patients.

Who Should Take This

Nurses, pharmacists, and prescribers with at least one year of clinical experience who regularly administer or prescribe medications should enroll. They seek to sharpen risk‑identification skills, master dosage calculations, and apply evidence‑based protocols for error reporting, patient education, and inter‑disciplinary communication.

What's Included in AccelaStudy® AI

Adaptive Knowledge Graph
Practice Questions
Lesson Modules
Console Simulator Labs
Exam Tips & Strategy
20 Activity Formats

Course Outline

65 learning goals
1 Rights of Medication Administration
1 topic

Five rights and additional rights

  • Recognize the five rights of medication administration: right patient, right drug, right dose, right route, and right time.
  • Describe the additional rights of medication administration including right documentation, right reason, right response, and right to refuse.
  • Explain verification procedures for each right including two-patient-identifier matching, allergy checking, independent double checks, and time-window compliance.
  • Recognize common medication administration errors including wrong-patient, wrong-dose, wrong-route, and wrong-time errors and their potential consequences.
  • Analyze medication administration scenarios to identify which right was violated and determine the appropriate corrective action.
2 High-Alert Medications
1 topic

ISMP high-alert medication categories

  • Identify the ISMP high-alert medication categories including anticoagulants, insulin, opioids, chemotherapy, concentrated electrolytes, and neuromuscular blocking agents.
  • Describe the specific safety protocols for anticoagulant administration including baseline lab monitoring, dosing protocols, reversal agent availability, and bleeding risk assessment.
  • Describe insulin safety practices including unit abbreviation prohibitions, concentration verification, independent double checks, and hypoglycemia management protocols.
  • Explain opioid safety measures including equianalgesic dosing, sedation scoring, naloxone availability, patient-controlled analgesia safety checks, and respiratory monitoring.
  • Analyze high-alert medication near-miss scenarios to identify system failures and recommend safeguards including independent double checks, dose limits, and forcing functions.
3 Look-Alike/Sound-Alike Medications
1 topic

LASA identification and prevention strategies

  • Recognize common look-alike/sound-alike medication pairs that are frequently confused in clinical practice.
  • Describe tall man lettering conventions and explain how they differentiate LASA medication names on labels, packaging, and electronic medication records.
  • Explain how barcode medication administration systems serve as a verification safeguard against LASA selection errors at the point of care.
  • Analyze medication dispensing and administration errors involving LASA pairs to identify contributing factors and recommend storage, labeling, and workflow improvements.
  • Identify automated dispensing cabinet strategies for separating LASA medications including physical separation, alert flags, and auxiliary labeling.
4 Medication Reconciliation
1 topic

Reconciliation at transitions of care

  • Describe the medication reconciliation process at admission including obtaining a complete medication history from multiple sources and comparing it to admission orders.
  • Explain medication reconciliation procedures at transfer and discharge including identification of discrepancies, resolution with the prescriber, and patient communication.
  • Recognize common discrepancy types found during medication reconciliation including omissions, duplications, dosage changes, and therapeutic substitutions.
  • Analyze a medication reconciliation scenario to identify discrepancies, prioritize resolution based on clinical significance, and determine appropriate prescriber communication.
  • Synthesize a standardized medication reconciliation workflow for a hospital unit incorporating best obtainable medication history, prescriber communication, and patient engagement.
  • Describe outpatient and ambulatory care medication reconciliation including primary care visit reconciliation, specialty referral handoffs, and pharmacy-led reconciliation programs.
5 Drug Interactions
1 topic

Pharmacokinetic and pharmacodynamic interactions

  • Describe pharmacokinetic drug interactions affecting absorption, distribution, metabolism, and excretion and explain how they alter drug levels.
  • Explain the role of CYP450 enzyme inhibition and induction in drug-drug interactions and identify clinically significant CYP450 substrate-inhibitor-inducer combinations.
  • Describe pharmacodynamic drug interactions including additive, synergistic, and antagonistic effects with emphasis on sedation stacking, QT prolongation, and serotonin syndrome.
  • Analyze a patient's medication regimen to identify potential drug-drug and drug-food interactions and determine their clinical significance and management approach.
  • Identify clinically significant drug-food interactions including grapefruit juice effects on CYP3A4 substrates, vitamin K intake with warfarin, tyramine-rich foods with MAOIs, and calcium-chelation effects on antibiotics.
  • Describe drug-herbal supplement interactions including St. John's wort effects on serotonergic and antiretroviral drugs, ginkgo biloba with anticoagulants, and garlic supplements with antiplatelet agents.
6 Dosage Calculations
1 topic

Weight-based, pediatric, and renal dosing

  • Describe weight-based dosing calculations including mg/kg conversions, total daily dose determination, and dose-per-interval calculations.
  • Explain pediatric dose verification methods including mg/kg calculations, body surface area dosing, and comparison against maximum recommended doses.
  • Describe renal dose adjustments using creatinine clearance estimates including the Cockcroft-Gault equation and dosing table interpretation.
  • Explain IV infusion rate calculations including mL/hr, mcg/kg/min, and units/hr conversions for continuous infusions and titration protocols.
  • Analyze dosing scenarios involving obese, pediatric, or renally impaired patients to calculate the correct dose, identify overdose risk, and verify the prescribed dose is appropriate.
7 Controlled Substance Management
1 topic

DEA schedules, counting, and diversion prevention

  • Identify the DEA controlled substance schedules I through V and the characteristics that determine classification.
  • Describe controlled substance count and documentation procedures including shift-to-shift counts, automated dispensing cabinet reconciliation, and discrepancy resolution.
  • Explain waste documentation requirements for controlled substances including dual-witness verification, partial dose waste procedures, and documentation standards.
  • Recognize indicators of controlled substance diversion including unusual access patterns, frequent waste without witness, patient pain complaints, and documentation anomalies.
  • Analyze controlled substance discrepancy scenarios to determine the appropriate investigation steps, reporting obligations, and resolution procedures.
  • Describe prescriptive authority limitations and scope-of-practice boundaries for controlled substance prescribing across different healthcare provider roles.
8 Medication Error Reporting and Safety Culture
1 topic

Just culture, reporting, and root cause analysis

  • Describe just culture principles that distinguish human error, at-risk behavior, and reckless behavior and their implications for accountability and system improvement.
  • Explain the process for reporting medication errors and near misses including internal incident reporting systems and external reporting to ISMP MERP and FDA MedWatch.
  • Describe root cause analysis methodology as applied to medication errors including event reconstruction, contributing factor identification, and corrective action development.
  • Analyze a medication error event to classify the error type, identify contributing system factors, and recommend process improvements that address root causes.
  • Synthesize a unit-level medication safety improvement plan incorporating error trend analysis, targeted education, workflow redesign, and technology enhancements.
9 Technology-Enabled Medication Safety
1 topic

CPOE, BCMA, smart pumps, and clinical decision support

  • Describe how computerized provider order entry (CPOE) reduces medication errors through dose range checking, allergy alerts, duplicate therapy warnings, and formulary guidance.
  • Explain barcode medication administration (BCMA) workflow including patient wristband scanning, medication scanning, override documentation, and downtime procedures.
  • Describe smart infusion pump features including drug libraries, dose-error reduction software, hard and soft limits, and pump interoperability with the EHR.
  • Recognize alert fatigue as a risk factor for medication errors and describe strategies for optimizing clinical decision support to reduce unnecessary alerts.
  • Analyze smart pump compliance data and BCMA override rates to identify workaround behaviors and recommend interventions to improve technology adoption.
10 Patient Education for Medication Safety
1 topic

Teach-back, health literacy, and discharge counseling

  • Describe the teach-back method for verifying patient understanding of medication instructions including name, purpose, dose, timing, and side effects to report.
  • Explain health literacy assessment and its impact on medication safety including plain language communication, pictographic aids, and avoiding medical jargon.
  • Describe discharge medication counseling best practices including reviewing new medications, changed medications, discontinued medications, and when to contact the provider.
  • Synthesize a patient medication education plan for a complex discharge scenario addressing polypharmacy, low health literacy, and limited English proficiency.
  • Describe medication adherence strategies including pillbox organization, reminder systems, motivational interviewing techniques, and barrier identification for non-adherent patients.
  • Explain caregiver education requirements for medication administration including delegation of tasks, proper technique demonstration, recognizing adverse effects, and when to seek emergency care.
11 Immunization Administration
1 topic

Vaccine storage, preparation, and injection technique

  • Describe vaccine storage requirements including refrigerator and freezer temperature ranges, cold chain monitoring, and excursion reporting procedures.
  • Explain vaccine reconstitution procedures including diluent verification, mixing technique, beyond-use dating, and multi-dose vial handling.
  • Describe correct injection techniques for intramuscular, subcutaneous, and intradermal administration routes including site selection, needle gauge, and angle.
  • Recognize the signs and symptoms of anaphylaxis following immunization and describe the emergency management protocol including epinephrine administration.
  • Analyze a vaccine administration error scenario to identify the root cause, determine patient notification and monitoring requirements, and recommend process improvements.
12 High-Risk Populations
1 topic

Pediatric, geriatric, renal, hepatic, and obstetric considerations

  • Describe medication safety considerations for pediatric patients including weight-based dosing verification, concentration errors, and off-label use prevalence.
  • Explain geriatric medication safety concerns including polypharmacy, Beers Criteria medications, fall risk medications, anticholinergic burden, and age-related pharmacokinetic changes.
  • Describe medication safety considerations for patients with renal impairment including nephrotoxic drug identification, dose adjustment protocols, and monitoring parameters.
  • Explain hepatic impairment considerations for medication safety including drugs requiring hepatic dose adjustment, hepatotoxic medications, and monitoring strategies.
  • Describe medication safety in pregnancy and lactation including teratogenicity risk categories, lactation risk assessment, and shared decision-making principles.
  • Analyze a complex patient scenario involving multiple high-risk factors to identify medication safety risks and synthesize a comprehensive safety plan.

Scope

Included Topics

  • The five rights of medication administration (right patient, right drug, right dose, right route, right time) and additional rights including right documentation, right reason, and right response.
  • High-alert medications as defined by ISMP including anticoagulants (heparin, warfarin, DOACs), insulin, opioids, chemotherapy agents, concentrated electrolytes, and neuromuscular blocking agents.
  • Look-alike/sound-alike (LASA) medication pairs, tall man lettering conventions, confusion-prone drug names, and barcode verification as a safeguard against selection errors.
  • Medication reconciliation at transitions of care including admission, transfer, and discharge, with processes for identifying and resolving discrepancies.
  • Drug interactions including pharmacokinetic interactions (absorption, distribution, metabolism via CYP450 enzymes, excretion) and pharmacodynamic interactions, with emphasis on clinically significant pairs.
  • Dosage calculations including weight-based dosing, body surface area calculations, pediatric dose verification, renal dose adjustments using creatinine clearance, and concentration calculations for IV infusions.
  • Controlled substance management including DEA schedule classifications, count and documentation procedures, dual-witness waste requirements, diversion detection indicators, and regulatory compliance.
  • Medication error reporting and safety culture including just culture principles, near-miss reporting, root cause analysis, the ISMP Medication Errors Reporting Program (MERP), and blame-free reporting systems.
  • Technology-enabled medication safety including computerized provider order entry (CPOE), barcode medication administration (BCMA), smart infusion pumps with dose-error reduction software, and clinical decision support systems.
  • Patient education for medication safety including the teach-back method, health literacy assessment, discharge medication counseling, and communication strategies for limited English proficiency patients.
  • Immunization administration practices including vaccine storage and cold chain management, reconstitution procedures, correct injection technique by route, anaphylaxis recognition and management.
  • High-risk populations requiring special medication safety considerations including pediatric patients, geriatric patients with polypharmacy, patients with renal or hepatic impairment, and pregnant or lactating patients.

Not Covered

  • Advanced clinical pharmacology, drug development, or pharmacogenomics beyond the practitioner-level understanding needed for safe medication administration.
  • Pharmaceutical manufacturing, compounding beyond basic reconstitution, or pharmacy operations management not directly relevant to bedside medication safety.
  • Detailed insurance formulary management, prior authorization workflows, or pharmacy benefit design except where directly impacting patient safety at the point of care.
  • Academic research methodology for medication safety studies or clinical trial design beyond understanding how to report errors and participate in improvement initiatives.
  • Veterinary pharmacology or non-human medication administration.

CE Medication Safety is coming soon

Adaptive learning that maps your knowledge and closes your gaps.

Create Free Account to Be Notified